🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
This is a phase 3, multicenter, open-label, randomized active-controlled, p...
Status
Terminated
Location
California Cancer Associates for Research and Excellence
Start Date
2019-05-30
Trial ID
NCT03786094
Treatments Being Tested
Determine the safety and tolerability of POL6326 when used as a single mobi...
Status
Completed
Location
University of Kansas Cancer Center
Start Date
2012-04
Trial ID
NCT01413568
Treatments Being Tested
The purpose of this study is to investigate the effects of POL6326 (CXCR4 a...
Status
Completed
Location
Medical University of Graz
Start Date
2013-07
Trial ID
NCT01905475
Accurate evaluation of tumor boundaries in breast-conserving surgery is clo...
Status
Recruiting
Location
Yunnan Cancer Hospital
Start Date
2024-09-01
Trial ID
NCT06713161
Treatments Being Tested
Phase I study to determine and compare the safety/tolerability of single as...
Status
Completed
Location
German Red Cross Blood Service and Institute for Transfusion Medicine and Immunohematology of the Goethe University
Start Date
2012-02
Trial ID
NCT01841476
Treatments Being Tested
POL6326 will be given by i.v. infusion over 2 hours. Treatment will occur o...
Status
Completed
Location
St Luke's Cancer Institute
Start Date
2013-06
Trial ID
NCT01837095
Treatments Being Tested
This is a single-center, open-label, phase 1 dose escalation and dose expan...
Status
Not Yet Recruiting
Location
Cedars-Sinai Cancer at SOCC
Start Date
2026-01
Trial ID
NCT06981806
Treatments Being Tested
This is a multicenter Phase Ib/II, open-label, dose-escalation study to opt...
Status
Withdrawn
Location
Multiple Locations
Start Date
2022-03-16
Trial ID
NCT04826016
Treatments Being Tested
The purpose of this study is to determine whether POL6326 is safe and clini...
Status
Completed
Location
Department of Internal Medicine V
Start Date
2009-04
Trial ID
NCT01105403
Treatments Being Tested